We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

300115:SZSEShenzhen Everwin Precision Technology Co., Ltd. Class A Analysis

Data as of 2026-06-14 - not real-time

CN¥29.39

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Shenzhen Everwin Precision Technology trades at a trailing P/E of 73.5, far above the industry average of 36.8, indicating significant overvaluation despite a respectable 16.7% revenue growth year‑over‑year. The company’s margins remain thin (gross margin ~17%, net margin ~2.8%) and it carries a heavy debt load with a debt‑to‑equity ratio over 110%, while free cash flow is deeply negative, raising concerns about cash sustainability. The dividend yield is modest at 0.34% with a payout ratio of 32.5%, but the negative cash conversion suggests the payout may not be durable in the long run.
On the technical side, the stock sits just above its calculated support of ~29.07 CNY, with an RSI of 29 signaling oversold conditions, yet the MACD remains bearish and the 20‑day SMA is below the current price, pointing to a neutral‑to‑slightly bearish short‑term bias. Volume is trending lower, and 30‑day volatility exceeds 46%, underscoring heightened price swings. Together, the fundamentals and technicals suggest caution: potential short‑term bounce from oversold levels but limited upside without a clear earnings or cash‑flow turnaround.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • RSI in oversold territory suggesting a possible bounce
  • Proximity to technical support level
  • Bearish MACD signal limiting upside

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • High P/E relative to peers
  • Negative free cash flow and high debt
  • Modest revenue growth insufficient to justify valuation

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Exposure to growing EV and automation segments
  • Sustained overvaluation and weak profitability
  • Financial leverage and cash‑flow constraints

Key Metrics & Analysis

Financial Health

Revenue Growth16.70%
Profit Margin2.80%
P/E Ratio73.5
ROE6.91%
ROA2.46%
Debt/Equity112.97
P/B Ratio4.7
Op. Cash FlowCN¥238.4M
Free Cash FlowCN¥-2500781312
Industry P/E36.8

Technical Analysis

TrendNeutral
RSI29.2
SupportCN¥29.07
ResistanceCN¥39.86
MA 20CN¥34.44
MA 50CN¥34.00
MA 200CN¥35.32
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Target PriceCN¥25.83
Upside/Downside-12.10%
GradeOvervalued
TypeValue
Dividend Yield0.34%

Risk Assessment

Beta0.21
Volatility46.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.